Replies to post #140446 on Amarin Corp Plc (AMRN)

[sts66]

I disagree strongly, and frankly cannot understand why folks aren't reading this correctly and using some knowledge and common sense - 1st A is about what AMRN reps can say (only) to docs:

Amarin “bears the responsibility, going forward, of assuring that its communications to doctors regarding off-label use of Vascepa remain truthful and non-misleading.”

Think about all of the BPs that were fined billions for off-label promotions that turned out badly, like promoting TO DOCTORS that adolescents be prescribed anti-depressants that had no pediatric indication, leading so many suicides - those drugs were never promoted to consumers for that use.

I could go back and read the court filings to prove AMRN was seeking to promote off-label to doctors only, but it's not worth the time it would take. Pacira's case was also about what they could promote to surgeons.